2018
DOI: 10.1016/j.jvs.2017.05.127
|View full text |Cite
|
Sign up to set email alerts
|

Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients

Abstract: Lymphocele formation is relatively common after femoral VA-ECMO. There was a significantly higher incidence of lymphocele formation in diabetic patients requiring support for PGD after heart transplantation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
31
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(35 citation statements)
references
References 30 publications
(37 reference statements)
1
31
3
Order By: Relevance
“…:LI group n = 46No LI group n = 93Identify pre-cannulation variables that are associated with limb ischemia and selection criteria for using DPC for prevention of limb ischemiaNo LI group:DM 16 (17%)HT 28 (30%)Uremia 10 (11%)PVD 8 (9%)LI group:DM 10 (22%)HT 17 (37%)Uremia 8 (17%)PVD 11 (24%)NANo LI group: 69 (74%)LI group: 25 (54%)16.5 ± 0.8PCNA46 (33%)Rescue6 FrNABurrell, 2018 [26]R144 ptsComplications and outcomes of patients who were commenced on ECMO at a referring hospital compared with patients who had ECMO in a referral center for ECMO.S 35 (26%)CAD 35 (26%)DM 16 (12%)HF 69 (53%)CT 18 (13%)7 (4–11) days105 (72.9%)17–19 FrPCNA1 (0.7%)Pre-emptive9 FrResolved after DPC insertion at the referral centerVoicu, 2018 [27]R46 pts. with refractory CAAnalyze the feasibility and the time interval required for percutaneous cannulation versus anatomic landmark cannulation for va ECMO.S 21 (46%)DM 5 (11%)HT 17 (37%)HL 15 (33%)NA4 (9%)15–17-19 FrPCNA0Pre-emptive4 FrNASalna, 2018 [28]R192 pts. with CS:35% AMI23% PCS18% ADHF15% PGD8.9% otherIncidence of in-hospital lymphocele formation in VA-ECMO patients and identify predictors for its developmentDM 65 (33.9%)CKD 52 (27.1%PVD 19 (9.4%)4 (2–6) days120 (62.5%)15–17 FrSCD 88 (45.8%)Surgical16 (8.3%)Preventive based on Doppler signal at cannulation6–10 FrNALamb, 2017 [29]R91 patients:CS 73 (80%);ARF 14 (15%)PE 3 (4%)VAD failure 1 (1%)Evaluation of an ischemia prevention protocolHT 53 (58%)DM 26 (29%)HL 34 (37%)OB 30 (33%)CLD 15 (17%)PVD 6 (7%)CKD 27 (30%)9 days38 (42%)16-24 Fr on pressure-flow curve and pts.…”
Section: Methodsmentioning
confidence: 99%
“…:LI group n = 46No LI group n = 93Identify pre-cannulation variables that are associated with limb ischemia and selection criteria for using DPC for prevention of limb ischemiaNo LI group:DM 16 (17%)HT 28 (30%)Uremia 10 (11%)PVD 8 (9%)LI group:DM 10 (22%)HT 17 (37%)Uremia 8 (17%)PVD 11 (24%)NANo LI group: 69 (74%)LI group: 25 (54%)16.5 ± 0.8PCNA46 (33%)Rescue6 FrNABurrell, 2018 [26]R144 ptsComplications and outcomes of patients who were commenced on ECMO at a referring hospital compared with patients who had ECMO in a referral center for ECMO.S 35 (26%)CAD 35 (26%)DM 16 (12%)HF 69 (53%)CT 18 (13%)7 (4–11) days105 (72.9%)17–19 FrPCNA1 (0.7%)Pre-emptive9 FrResolved after DPC insertion at the referral centerVoicu, 2018 [27]R46 pts. with refractory CAAnalyze the feasibility and the time interval required for percutaneous cannulation versus anatomic landmark cannulation for va ECMO.S 21 (46%)DM 5 (11%)HT 17 (37%)HL 15 (33%)NA4 (9%)15–17-19 FrPCNA0Pre-emptive4 FrNASalna, 2018 [28]R192 pts. with CS:35% AMI23% PCS18% ADHF15% PGD8.9% otherIncidence of in-hospital lymphocele formation in VA-ECMO patients and identify predictors for its developmentDM 65 (33.9%)CKD 52 (27.1%PVD 19 (9.4%)4 (2–6) days120 (62.5%)15–17 FrSCD 88 (45.8%)Surgical16 (8.3%)Preventive based on Doppler signal at cannulation6–10 FrNALamb, 2017 [29]R91 patients:CS 73 (80%);ARF 14 (15%)PE 3 (4%)VAD failure 1 (1%)Evaluation of an ischemia prevention protocolHT 53 (58%)DM 26 (29%)HL 34 (37%)OB 30 (33%)CLD 15 (17%)PVD 6 (7%)CKD 27 (30%)9 days38 (42%)16-24 Fr on pressure-flow curve and pts.…”
Section: Methodsmentioning
confidence: 99%
“…Cardiac transplant patients on Tacrolimus -an immunosuppressant associated with the incidence of post-transplant diabetes -have an strong association to this complication; its incidence was significantly influenced by primary graft dysfunction. The authors note that lymphocele formation in these patients is probably due to the combination of manipulation of the femoral arteries in patients with diabetes, and high doses of immunosuppressants (33) . Therefore, when caring for transplanted patients during ECMO, the surveillance for this occurrence, persistence, volume, and infectious characteristics of possible inguinal drainage should and must be intensified.…”
Section: Predictors Of Complications Associated With Extracorporeal Mmentioning
confidence: 96%
“…The chance of severe thrombocytopenia increases by 35% with each 5 points increase in the APACHE II score, and each decrease in the platelet count of 25,000/μL from 188,000/μL after cannulation (19) . Primary cardiac graft dysfunction among transplanted individuals was associated with an 8.66 time increase in the chance of lymphocele (33) . For venous thromboembolism and venous thrombosis, one extra day in ECMO increases the chance by 4%, while a PTT > 50 sec decreases the chance by 3% (34) .…”
Section: Sample/ecmo Modality Objective Findings/multivariate Analysimentioning
confidence: 97%
See 2 more Smart Citations